NPI: 1861581043 · LOS ANGELES, CA 90029 · Community Health Clinic/Center · NPI assigned 10/12/2006
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 10/12/2006 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 32,501 | $1.70M |
| 2019 | 16,715 | $922K |
| 2020 | 14,944 | $528K |
| 2021 | 19,989 | $920K |
| 2022 | 15,183 | $749K |
| 2023 | 18,618 | $953K |
| 2024 | 14,542 | $729K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,540 | 4,341 | $930K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 12,038 | 10,840 | $740K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,532 | 5,082 | $713K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,910 | 1,835 | $604K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5,949 | 5,576 | $586K |
| J3490 | Unclassified drugs | 14,302 | 12,039 | $526K |
| S4993 | Contraceptive pills for birth control | 5,480 | 5,444 | $488K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,069 | 1,997 | $388K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 302 | 301 | $265K |
| 87806 | 8,565 | 6,723 | $216K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 489 | 468 | $186K |
| 99201 | 1,204 | 1,135 | $149K | |
| A4267 | Contraceptive supply, condom, male, each | 13,025 | 12,786 | $107K |
| J7304 | Contraceptive supply, hormone containing patch, each | 294 | 294 | $91K |
| 11981 | 302 | 302 | $69K | |
| 81025 | 16,956 | 16,234 | $59K | |
| 58300 | 568 | 277 | $53K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 3,607 | 3,607 | $46K |
| 11976 | 707 | 356 | $41K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 505 | 503 | $38K |
| S5000 | Prescription drug, generic | 5,526 | 5,222 | $35K |
| 83986 | 9,844 | 7,989 | $27K | |
| 57454 | 401 | 201 | $25K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 5,913 | 5,731 | $22K |
| 99401 | 999 | 999 | $19K | |
| 86703 | 1,366 | 1,101 | $14K | |
| 58301 | 425 | 216 | $13K | |
| 99000 | 3,440 | 3,416 | $12K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 13 | 13 | $9K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 548 | 518 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 577 | 547 | $7K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 1,204 | 1,169 | $5K |
| 81002 | 2,303 | 2,230 | $4K | |
| 82120 | 593 | 575 | $2K | |
| 87210 | 575 | 557 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 256 | 216 | $1K |
| 99402 | 14 | 14 | $445.06 | |
| 86592 | 139 | 139 | $416.08 | |
| S5001 | Prescription drug, brand name | 12 | 12 | $145.00 |